Skip to content
Open access

Cortical and subcortical morphological alterations in de novo GBA-related Parkinson’s disease

Aug 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 38 references
Medicine

TL;DR

GBA-PD patients showed distinct patterns of cortical thickness and volume thinning, as well as amygdala subregional atrophy, which may contribute to future exploratory phenotypic characterization or patient stratification, but validation in larger independent cohorts is required.

Abstract

Background This study aimed to investigate cortical and subcortical changes in GBA-related Parkinson’s disease (GBA-PD) patients and evaluate the ability of these structural changes to identify patients with GBA-PD. Methods T1-weighted magnetic resonance imaging images were obtained for 86 participants, including 19 GBA-PD, 42 idiopathic PD (iPD) cases, and 25 healthy controls (HCs). Cortical thickness, cortical volume, and subcortical volume (including amygdala volume) were calculated to identify cortical and subcortical morphological alterations and correlated with cognitive function. To reduce overfitting, classification was performed using least absolute shrinkage and selection operator (LASSO)-penalized logistic regression with nested stratified 5-fold cross-validation. Results Compared with iPD patients, GBA-PD patients had reduced cortical thickness in the left superior temporal sulcus (STS.L) and left superior occipital gyrus (SOG.L) as well as reduced cortical volume in the SOG.L and right amygdala subregion, including the basal nucleus, accessory basal nucleus, cortico-amygdaloid transition area, and paralaminar nucleus. Cortical thickness and cortical volume in the SOG.L, right basal nucleus, and right paralaminar nucleus were negatively correlated with memory and visuospatial function, respectively. After internal cross-validation, the exploratory LASSO-based model combining age, sex, and significant cortical and subcortical morphometric features showed moderate discrimination between GBA-PD and iPD, with an area under the curve of 0.821, sensitivity of 56.3%, and specificity of 88.1%. Conclusion GBA-PD patients showed distinct patterns of cortical thickness and volume thinning, as well as amygdala subregional atrophy. These cortical and subcortical changes may contribute to future exploratory phenotypic characterization or patient stratification, but validation in larger independent cohorts is required.

Read PDF

Similar papers

Open access Sep 2026

Diabetes status associates with entorhinal cortical thinning in Parkinson's disease.

OBJECTIVE Our study aimed to investigate cortical thickness (CT) alterations in Parkinson's disease (PD) patients with and without diabetes mellitus (DM), and explore the correlation between DM, CT, and cognitive function. METHODS A total of 135 participants were enrolled, including 16 PD patients with DM (PD-DM), 87...

Xin-Xin Ma, Hui-Jing Liu, Yue-Ying Liu et al. · 0 citations
Sep 2026

Correlating lesion localization within the functional cortical networks in sleep related epilepsy caused by focal cortical dysplasia type II.

BACKGROUND To investigate whether the co-localization of focal cortical dysplasia (FCD) type II within the distributed cortical networks and the presence of alteration in the subcortical structures were associated with sleep related epilepsy (SRE) in patients with FCD type II. METHODS Epileptic patients with histolog...

Jing Hu, Wen-Xin Wu, Hong Li et al. · 0 citations
Sep 2026

Macro-structural brainstem volumetry in generalized epilepsy: assessment of subcortical network involvement

The anatomical basis of Generalized Epilepsy may involve a structural process encompassing the brainstem and affecting deep brain structures, and the detected volume reduction in the medulla oblongata could be associated with a potential disruption in cardiorespiratory regulation.

M. Karagulle, Nuriye Oz, Kamil Karaali et al. · 0 citations
Open access Aug 2026

Magnetic Resonance Imaging-Based Cortical and Subcortical Volumetric Changes in Alzheimer’s Disease: Association with Clinical Severity

Automated MRI volumetry may support the quantitative assessment of neurodegeneration in clinically defined AD and MCI, although these findings require external validation in larger, longitudinal, biomarker-characterized cohorts.

A. Alagoz, Serap Ozturk, S. D. Bunul et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.